100 related articles for article (PubMed ID: 15304273)
1. The use of OP-1 in femoral impaction grafting in a sheep model.
McGee MA; Findlay DM; Howie DW; Carbone A; Ward P; Stamenkov R; Page TT; Bruce WJ; Wildenauer CI; Toth C
J Orthop Res; 2004 Sep; 22(5):1008-15. PubMed ID: 15304273
[TBL] [Abstract][Full Text] [Related]
2. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants.
Jensen TB; Overgaard S; Lind M; Rahbek O; Bünger C; Søballe K
Acta Orthop Scand; 2002 Jan; 73(1):31-9. PubMed ID: 11928908
[TBL] [Abstract][Full Text] [Related]
3. A preclinical study of stem subsidence and graft incorporation after femoral impaction grafting using porous hydroxyapatite as a bone graft extender.
Howie DW; McGee MA; Callary SA; Carbone A; Stamenkov RB; Bruce WJ; Findlay DM
J Arthroplasty; 2011 Oct; 26(7):1050-6. PubMed ID: 21802252
[TBL] [Abstract][Full Text] [Related]
4. A combination of bisphosphonate and BMP additives in impacted bone allografts.
Jeppsson C; Astrand J; Tägil M; Aspenberg P
Acta Orthop Scand; 2003 Aug; 74(4):483-9. PubMed ID: 14521303
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.
Baas J
Acta Orthop Suppl; 2008 Aug; 79(330):1-43. PubMed ID: 19065776
[TBL] [Abstract][Full Text] [Related]
6. High doses of OP-1 inhibit fibrous tissue ingrowth in impaction grafting.
Hannink G; Aspenberg P; Schreurs BW; Buma P
Clin Orthop Relat Res; 2006 Nov; 452():250-9. PubMed ID: 16906082
[TBL] [Abstract][Full Text] [Related]
7. Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo.
Ma T; Gutnick J; Salazar B; Larsen MD; Suenaga E; Zilber S; Huang Z; Huddleston J; Smith RL; Goodman S
Bone; 2007 Sep; 41(3):386-92. PubMed ID: 17613298
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1.
Tsiridis E; Ali Z; Bhalla A; Heliotis M; Gurav N; Deb S; DiSilvio L
J Orthop Res; 2007 Nov; 25(11):1425-37. PubMed ID: 17557338
[TBL] [Abstract][Full Text] [Related]
9. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model.
Phillips FM; Turner AS; Seim HB; MacLeay J; Toth CA; Pierce AR; Wheeler DL
Spine J; 2006; 6(5):500-6. PubMed ID: 16934718
[TBL] [Abstract][Full Text] [Related]
10. Use of mesenchymal stem cells to enhance bone formation around revision hip replacements.
Korda M; Blunn G; Goodship A; Hua J
J Orthop Res; 2008 Jun; 26(6):880-5. PubMed ID: 18271017
[TBL] [Abstract][Full Text] [Related]
11. No positive effects of OP-1 device on the incorporation of impacted graft materials after 8 weeks: a bone chamber study in goats.
Hannink G; Schreurs BW; Buma P
Acta Orthop; 2007 Aug; 78(4):551-8. PubMed ID: 17966011
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of short-term healing following sustained delivery of osteoinductive agents in a rat femur drill defect model.
Wingerter S; Tucci M; Bumgardner J; Benghuzzi H
Biomed Sci Instrum; 2007; 43():188-93. PubMed ID: 17487079
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of OP-1 and antibiotics in treatment of femoral defects in male rats.
Dzugan S; Galjour C; Conflitti J; Benghuzzi H; Tucci M; Russell G; Tsao A
Biomed Sci Instrum; 2005; 41():80-5. PubMed ID: 15850086
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur.
Chen X; Kidder LS; Lew WD
J Orthop Res; 2002 Jan; 20(1):142-50. PubMed ID: 11853081
[TBL] [Abstract][Full Text] [Related]
15. Ectopic bone formation using osteogenic protein-1 carried by a solution precipitated hydroxyapatite.
Zhang R; Xu D; Landeryou T; Toth C; Dimaano N; Berry J; Evans J; Hawkins M
J Biomed Mater Res A; 2004 Dec; 71(3):412-8. PubMed ID: 15472924
[TBL] [Abstract][Full Text] [Related]
16. No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model.
Tägil M; Jeppsson C; Wang JS; Aspenberg P
Acta Orthop Scand; 2003 Dec; 74(6):742-8. PubMed ID: 14763709
[TBL] [Abstract][Full Text] [Related]
17. New bone formation by murine osteoprogenitor cells cultured on corticocancellous allograft bone.
Nelson ER; Huang Z; Ma T; Lindsey D; Jacobs C; Smith RL; Goodman SB
J Orthop Res; 2008 Dec; 26(12):1660-4. PubMed ID: 18524004
[TBL] [Abstract][Full Text] [Related]
18. Safety of epidural administration of Osteogenic Protein-1 (OP-1/BMP-7): behavioral and macroscopic observation.
Kawakami M; Hashizume H; Matsumoto T; Enyo Y; Okada M; Yoshida M; Chubinskaya S
Spine (Phila Pa 1976); 2007 Jun; 32(13):1388-93. PubMed ID: 17545905
[TBL] [Abstract][Full Text] [Related]
19. Tendon reattachment to a metallic implant using an allogenic bone plate augmented with rhOP-1 vs. autogenous cancellous bone and marrow in a canine model.
Higuera CA; Inoue N; Lim JS; Zhang R; Dimaano N; Frassica FJ; Chao EY
J Orthop Res; 2005 Sep; 23(5):1091-9. PubMed ID: 16140192
[TBL] [Abstract][Full Text] [Related]
20. Impaction grafting with a bone-graft substitute in a sheep model of revision hip replacement.
Coathup M; Smith N; Kingsley C; Buckland T; Dattani R; Ascroft GP; Blunn G
J Bone Joint Surg Br; 2008 Feb; 90(2):246-53. PubMed ID: 18256099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
